Notifications

Home

Stocks
- Stock Screener
- Market Movers
- Insider Trades
- Upcoming Earnings
- Upcoming Dividends
Options
- Unusual Options Activity
- Implied Volatility Rank
- Volatility %Change
News
Upcoming IPOs

Allarity Therapeutics Inc (ALLR)

$0.94 +0.02 (2.20%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	14.83M
Revenue (ttm)	0.00
Net Income (ttm)	-24.52M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.12

Volume	73,800
Avg Vol	167,164
Day's Range	N/A - N/A
Shares Out	16.08M
Stochastic %K	51%
Beta	0.24
Analysts	Sell
Price Target	$9.50

Company Profile

Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing novel anti-cancer therapeutics for patients with unmet medical needs. The company develops drugs for the personalized treatment of cancer using drug specific companion diagnostics generated by its proprietary drug response predictor technology. Its lead drug candidate includes Stenoparib, a novel dual inhibitor of poly-ADP-ribose polymerase (PARP1/2) that is being evaluated in a phase 2...

Industry: Biotechnology

Sector: Healthcare

Phone: 401 426 4664

Website: www.allarity.com

Address:

24 School Street, 2nd Floor, Boston, United States

Kvakklunch Feb. 23 at 10:37 AM

$ALLR I wonder if they pump it up 10% premarket then dump it -15% for maximum pain?

1 · Reply

TradPoof Feb. 23 at 9:49 AM

$ALLR Funny stock, + & minus 15%. watch if over & $1.05

0 · Reply

RAKIN13 Feb. 23 at 12:12 AM

$ALLR what are we expecting this week?😅

1 · Reply

ExtinctionBurst Feb. 22 at 4:24 AM

$ALLR VA Clinical Trial Milestone (Feb 18, 2026): Allarity announced that the first patients have been dosed in a Phase 2 clinical trial for relapsed small cell lung cancer (SCLC). This trial is notably fully funded by the U.S. Department of Veterans Affairs and is being conducted across 11 VA medical centers.

0 · Reply

TheSuper Feb. 21 at 2:40 AM

$ALLR .9999 price... bothing suspicious about that.

1 · Reply

Carny Feb. 20 at 9:23 PM

$ALLR another sell the news day.

0 · Reply

Ugly1 Feb. 20 at 8:56 PM

$ALLR won’t be long now and I’ll get back in…😂. Mid eighties incoming

2 · Reply

Kvakklunch Feb. 20 at 6:26 PM

$ALLR Market is pumping, this stock is dumping!

0 · Reply

Mikess1 Feb. 20 at 3:42 PM

$ALLR Hopefully this is testing support, then bounce back up again.

2 · Reply

Kvakklunch Feb. 20 at 2:52 PM

$ALLR The rally and the buybacks are done. Let's welcome all the new bagholders, I mean shareholders. Red day today...

2 · Reply

Allarity Therapeutics Doses First Patients in VA-Funded Phase 2 Trial Focused on Small Cell Lung Cancer with High Unmet Need

Feb 3, 2026, 8:00 AM EST - 20 days ago

Allarity Therapeutics announces that its collaborative Phase 2 trial with the United States Veteran's Administration Combining Stenoparib with Temozolomide in Relapsed Small Cell Lung Cancer is Now Open for Enrollment

Dec 31, 2025, 8:00 AM EST - 7 weeks ago

Allarity Therapeutics Issues 2025 End of Year CEO Letter to Shareholders

Nov 14, 2025, 9:00 AM EST - 3 months ago

Allarity Therapeutics Provides Third Quarter 2025 Financial Results and Provides Business Updates

Sep 22, 2025, 8:00 AM EDT - 5 months ago

Allarity Therapeutics Presents New Phase 2 Clinical Data for Stenoparib/2X-121 Showing Landmark Median Overall Survival Has Now Surpassed 25 Months

Sep 17, 2025, 8:00 AM EDT - 5 months ago

Allarity Therapeutics CEO to Present at Biomarkers & Precision Medicine 2025

Aug 26, 2025, 8:00 AM EDT - 6 months ago

Allarity Therapeutics Granted FDA Fast Track Designation for Stenoparib for the Treatment of Advanced Ovarian Cancer

Aug 15, 2025, 4:30 PM EDT - 6 months ago

Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships

Jul 15, 2025, 8:00 AM EDT - 7 months ago

Allarity Therapeutics Announces New Licensing and Laboratory Services Agreement to Expand DRP® Platform Utilization

Jul 7, 2025, 8:00 AM EDT - 8 months ago

Allarity Therapeutics Announces Appointment of Jeff Ervin as Chief Financial Officer

Jun 27, 2025, 8:00 AM EDT - 8 months ago

Allarity Therapeutics Announces Dosing of Second Patient in New Phase 2 Trial of Stenoparib in Advanced Ovarian Cancer

Jun 11, 2025, 4:05 PM EDT - 9 months ago

Allarity Therapeutics Announces Changes to Board of Directors

May 9, 2025, 4:05 PM EDT - 10 months ago

Allarity Therapeutics Provides First Quarter 2025 Update, Highlighting Continued Stenoparib Benefit and Upcoming Trial Enrollment

Apr 14, 2025, 9:04 AM EDT - 11 months ago

ALLR Shareholders are Encouraged to Join Allarity Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm

Mar 14, 2025, 4:30 AM EDT - 1 year ago

ALLR Investors Have Opportunity to Join Allarity Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm

Mar 13, 2025, 8:30 AM EDT - 1 year ago

Allarity Therapeutics Announces Final Settlement with the U.S. Securities and Exchange Commission

Mar 6, 2025, 8:00 AM EST - 1 year ago

Allarity Therapeutics Announces Phase 2 Trial of Stenoparib in Combination with Temozolomide for Recurrent Small Cell Lung Cancer Fully Funded by the US Veterans Administration

Feb 24, 2025, 8:00 AM EST - 1 year ago

Allarity Therapeutics to Begin Enrollment for New Phase 2 Protocol to Advance Stenoparib Toward FDA Approval in Advanced Ovarian Cancer Patients

Feb 14, 2025, 10:00 AM EST - 1 year ago

Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Feb 13, 2025, 10:00 AM EST - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Encourages Allarity Therapeutics, Inc. (ALLR) Shareholders to Inquire about Securities Investigation

Feb 12, 2025, 10:00 AM EST - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Allarity Therapeutics, Inc. (ALLR) And Encourages Shareholders to Connect

Feb 11, 2025, 10:00 AM EST - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Allarity Therapeutics, Inc. (ALLR) And Encourages Shareholders to Reach Out

Feb 10, 2025, 10:00 AM EST - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Encourages Allarity Therapeutics, Inc. (ALLR) Stockholders to Inquire about Securities Investigation

Feb 9, 2025, 10:00 AM EST - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Allarity Therapeutics, Inc. (ALLR) and Encourages Investors to Learn More About the Investigation

Feb 7, 2025, 10:00 AM EST - 1 year ago

Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Feb 6, 2025, 10:00 AM EST - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Allarity Therapeutics, Inc. (ALLR) And Encourages Investors to Connect

Feb 6, 2025, 8:00 AM EST - 1 year ago

Allarity Therapeutics Announces Expansion of Phase 2 Clinical Trial to Accelerate Development of Stenoparib in Advanced Ovarian Cancer

Feb 4, 2025, 10:00 AM EST - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Encourages Allarity Therapeutics, Inc. (ALLR) Investors to Inquire about Securities Investigation

Feb 3, 2025, 10:00 AM EST - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Allarity Therapeutics, Inc. (ALLR) And Encourages Investors to Reach Out

Feb 2, 2025, 10:00 AM EST - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Allarity Therapeutics, Inc. (ALLR) And Encourages Stockholders to Reach Out

Jan 31, 2025, 10:00 AM EST - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Allarity Therapeutics, Inc. (ALLR) And Encourages Stockholders to Connect

Jan 30, 2025, 8:00 AM EST - 1 year ago

Allarity Therapeutics Announces Filing of Form 8-K Regarding Settlement Agreement in Principle with SEC

Jan 8, 2025, 10:00 AM EST - 1 year ago

Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Jan 5, 2025, 10:00 AM EST - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Allarity Therapeutics, Inc. (ALLR) and Encourages Stockholders to Learn More About the Investigation

Nov 18, 2024, 8:00 AM EST - 1 year ago

Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements

Nov 11, 2024, 3:45 PM EST - 1 year ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics

Nov 11, 2024, 11:15 AM EST - 1 year ago

DEADLINE TOMORROW: Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Investors Are Invited To Reach Out To The Schall Law Firm

Nov 9, 2024, 12:30 PM EST - 1 year ago

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Investors With Losses Are Invited To Contact The Schall Law Firm

Nov 8, 2024, 7:00 PM EST - 1 year ago

ALLR Deadline: Rosen Law Firm Urges Allarity Therapeutics, Inc. (NASDAQ: ALLR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Nov 8, 2024, 9:45 AM EST - 1 year ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics

Nov 7, 2024, 11:00 AM EST - 1 year ago

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Investors With Losses Should Contact The Schall Law Firm

Nov 6, 2024, 11:00 AM EST - 1 year ago

The Schall Law Firm Encourages Stockholder Participation In A Case Against Allarity Therapeutics, Inc. For Fraud

Nov 4, 2024, 11:00 AM EST - 1 year ago

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Investors With Losses Are Urged To Help The Schall Law Firm

Nov 2, 2024, 11:00 AM EDT - 1 year ago

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Investors With Losses Are Urged To Contact The Schall Law Firm

Kvakklunch Feb. 23 at 10:37 AM

$ALLR I wonder if they pump it up 10% premarket then dump it -15% for maximum pain?

1 · Reply

TradPoof Feb. 23 at 9:49 AM

$ALLR Funny stock, + & minus 15%. watch if over & $1.05

0 · Reply

RAKIN13 Feb. 23 at 12:12 AM

$ALLR what are we expecting this week?😅

1 · Reply

ExtinctionBurst Feb. 22 at 4:24 AM

0 · Reply

TheSuper Feb. 21 at 2:40 AM

$ALLR .9999 price... bothing suspicious about that.

1 · Reply

Carny Feb. 20 at 9:23 PM

$ALLR another sell the news day.

0 · Reply

Ugly1 Feb. 20 at 8:56 PM

$ALLR won’t be long now and I’ll get back in…😂. Mid eighties incoming

2 · Reply

Kvakklunch Feb. 20 at 6:26 PM

$ALLR Market is pumping, this stock is dumping!

0 · Reply

Mikess1 Feb. 20 at 3:42 PM

$ALLR Hopefully this is testing support, then bounce back up again.

2 · Reply

Kvakklunch Feb. 20 at 2:52 PM

$ALLR The rally and the buybacks are done. Let's welcome all the new bagholders, I mean shareholders. Red day today...

2 · Reply

RAKIN13 Feb. 20 at 2:36 PM

$ALLR what are we expecting today?

2 · Reply

Stock_Catcher Feb. 20 at 2:58 AM

Fortune Friday Watchlist Pt. 8 $FJET $ALLR $CAPR $CADL $SOFI Let's Feast Bulls

0 · Reply

Bigbeto Feb. 20 at 2:49 AM

$ALLR at $1.12 someone knows something runnig to 1.25 at least

2 · Reply

TradPoof Feb. 20 at 2:09 AM

$ALLR Easy hold, break $1 💰💰💰

0 · Reply

Ugly1 Feb. 20 at 12:39 AM

$ALLR sold today thank goodness. Will buy back when it drops again, and it will, it always does

1 · Reply

ZdP2 Feb. 20 at 12:05 AM

$ALLR Another nice call, up 22% in 11 days. Too bad I didn't have the cash at the time to follow through on my buy... : /

0 · Reply

Dizzier47 Feb. 19 at 8:17 PM

$ALLR cya at 2$ bears

1 · Reply

Mikess1 Feb. 19 at 7:30 PM

$ALLR soo??? Where are the grizzly bears? Margin call yet chaps? Can’t wait until it comes because this baby is spring loaded

1 · Reply

TinyTiger19 Feb. 19 at 7:23 PM

$ALLR $TMDE $ARTL $CBIO ~~~

0 · Reply

Mikess1 Feb. 19 at 6:15 PM

$ALLR she’s broke through and off 🤌🏻

1 · Reply

Mikess1 Feb. 19 at 3:06 PM

$ALLR Will today be the day she breaks and holds!

1 · Reply

Mikess1 Feb. 19 at 2:40 PM

$ALLR gaining some traction with some big accounts coming in, it's only a matter of time :) just have to be concerned when the Professor shows face!

1 · Reply

1.0.0